Cambridge Investment Research Advisors’s Balchem Corp BCPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $389K | Sell |
2,303
-36
| -2% | -$5.98K | ﹤0.01% | 3200 |
|
|
2026
Q1 | $396K | Sell |
2,339
-121
| -5% | -$20.5K | ﹤0.01% | 3024 |
|
|
2025
Q4 | $377K | Sell |
2,460
-335
| -12% | -$51.1K | ﹤0.01% | 2983 |
|
|
2025
Q3 | $419K | Sell |
2,795
-4,904
| -64% | -$773K | ﹤0.01% | 2830 |
|
|
2025
Q2 | $1.23M | Sell |
7,699
-1,691
| -18% | -$274K | ﹤0.01% | 1799 |
|
|
2025
Q1 | $1.56M | Buy |
9,390
+6,654
| +243% | +$1.09M | 0.01% | 1517 |
|
|
2024
Q4 | $446K | Sell |
2,736
-441
| -14% | -$76.5K | ﹤0.01% | 2523 |
|
|
2024
Q3 | $559K | Sell |
3,177
-408
| -11% | -$69.5K | ﹤0.01% | 2317 |
|
|
2024
Q2 | $552K | Sell |
3,585
-408
| -10% | -$61.4K | ﹤0.01% | 2220 |
|
|
2024
Q1 | $619K | Sell |
3,993
-950
| -19% | -$141K | ﹤0.01% | 2089 |
|
|
2023
Q4 | $735K | Sell |
4,943
-2,992
| -38% | -$382K | ﹤0.01% | 1869 |
|
|
2023
Q3 | $984K | Buy |
7,935
+386
| +5% | +$51.3K | ﹤0.01% | 1596 |
|
|
2023
Q2 | $1.02M | Sell |
7,549
-26
| -0.3% | -$3.34K | ﹤0.01% | 1602 |
|
|
2023
Q1 | $958K | Sell |
7,575
-262
| -3% | -$33.9K | ﹤0.01% | 1603 |
|
|
2022
Q4 | $957K | Sell |
7,837
-182
| -2% | -$24K | 0.01% | 1539 |
|
|
2022
Q3 | $975K | Sell |
8,019
-164
| -2% | -$21.4K | 0.01% | 1497 |
|
|
2022
Q2 | $1.06M | Buy |
8,183
+182
| +2% | +$22.8K | 0.01% | 1440 |
|
|
2022
Q1 | $1.09M | Sell |
8,001
-602
| -7% | -$86.2K | 0.01% | 1513 |
|
|
2021
Q4 | $1.45M | Buy |
8,603
+181
| +2% | +$29.1K | 0.01% | 1340 |
|
|
2021
Q3 | $1.22M | Sell |
8,422
-804
| -9% | -$109K | 0.01% | 1383 |
|
|
2021
Q2 | $1.21M | Buy |
9,226
+293
| +3% | +$37.7K | 0.01% | 1392 |
|
|
2021
Q1 | $1.12M | Buy |
8,933
+399
| +5% | +$48.5K | 0.01% | 1357 |
|
|
2020
Q4 | $983K | Buy |
8,534
+422
| +5% | +$44.5K | 0.01% | 1314 |
|
|
2020
Q3 | $792K | Buy |
8,112
+803
| +11% | +$78.7K | 0.01% | 1323 |
|
|
2020
Q2 | $693K | Buy |
7,309
+1,067
| +17% | +$99.8K | 0.01% | 1349 |
|
|
2020
Q1 | $616K | Buy |
6,242
+987
| +19% | +$101K | 0.01% | 1249 |
|
|
2019
Q4 | $534K | Buy |
5,255
+187
| +4% | +$18.9K | ﹤0.01% | 1537 |
|
|
2019
Q3 | $503K | Buy |
5,068
+205
| +4% | +$19.5K | ﹤0.01% | 1490 |
|
|
2019
Q2 | $486K | Buy |
4,863
+149
| +3% | +$14.5K | ﹤0.01% | 1446 |
|
|
2019
Q1 | $437K | Buy |
4,714
+169
| +4% | +$14.6K | ﹤0.01% | 1579 |
|
|
2018
Q4 | $356K | Buy |
4,545
+1,214
| +36% | +$110K | ﹤0.01% | 1543 |
|
|
2018
Q3 | $373K | Buy |
3,331
+143
| +4% | +$15K | ﹤0.01% | 1642 |
|
|
2018
Q2 | $313K | Sell |
3,188
-45
| -1% | -$4.19K | ﹤0.01% | 1703 |
|
|
2018
Q1 | $264K | Buy |
3,233
+13
| +0.4% | +$1.02K | ﹤0.01% | 1763 |
|
|
2017
Q4 | $259K | Sell |
3,220
-190
| -6% | -$15.8K | ﹤0.01% | 1749 |
|
|
2017
Q3 | $277K | Sell |
3,410
-204
| -6% | -$15.7K | ﹤0.01% | 1601 |
|
|
2017
Q2 | $281K | Buy |
+3,614
| New | +$288K | ﹤0.01% | 1548 |
|
Other funds holding BCPC
CCA
WA
GCM
Cambridge Investment Research Advisors's BCPC Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Balchem Corp (BCPC) stake by 1.5% in Q2 2026, selling an estimated $5.98K and leaving 2,303 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.
Cambridge Investment Research Advisors first reported a position in BCPC in Q2 2017 and has held it in 37 quarters since. The position peaked at $1.56M in Q1 2025. 416 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.
- Cambridge Investment Research Advisors held 2,303 shares of Balchem Corp worth $389K as of Q2 2026.
- Cambridge Investment Research Advisors sold 36 Balchem Corp shares in Q2 2026, an estimated $5.98K.
- Balchem Corp made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3200 holding.
- Cambridge Investment Research Advisors first reported a position in Balchem Corp in Q2 2017 and has held it in 37 quarters since.
- Cambridge Investment Research Advisors's Balchem Corp position peaked at $1.56M in Q1 2025.
- 416 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.